ARTICLE | Clinical News
GA-II: Began Phase I trials
January 4, 2000 8:00 AM UTC
Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Product: GA-II Business: Gene/Cell therapy Therapeutic category: Gene therapy Target: Undisclosed Description: Gene activated protein product Indi...